SEC Form 4 · accession 0001209191-19-000590
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Tarriff
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 2, 2019 · 9:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.87 | Dec 31, 2018 | A | 126,700 | A | — | Dec 31, 2028 | Common Stock | 126,700 | 126,700 | D |
Explanation of responses
- F1126,700 options vest on 12/31/2019.